Search research articles
Contact Us
Filters
Showing results (361-370 of 721) with videos related to
Page
of 73
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 18, 2008
SPECT/CT
Andreas K Buck, Stephan Nekolla, Sibylle Ziegler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 23, 2026
PSMA-PET response under [<sup>177</sup>Lu]Lu-PSMA therapy: Comparison of RECIST, PERCIST, PPP, adapted PCWG4 and RECIP criteria
Tugce Telli, Madeleine J Karpinski, Robert Seifert, et al.
Oncotarget
|
July 1, 2014
Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCL
Ken Herrmann, Andreas K Buck, Tibor Schuster, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 17, 2024
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials
Caroline Stokke, Silvano Gnesin, Johannes Tran-Gia, et al.
European Urology
|
October 20, 2024
Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers
Martina Sollini, Jeremie Calais, Arturo Chiti, et al.
Nuclear Medicine Communications
|
September 12, 2018
Impact of prompt gamma coincidence correction on absorbed dose estimation in differentiated thyroid cancer using 124I PET/CT imaging
Roel Wierts, Maurizio Conti, Anouk G G Claessen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 3, 2021
Novel CYP11B-ligand [<sup>123/131</sup>I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Britta Heinze, Andreas Schirbel, Lukas Nannen, et al.
Acta Biomaterialia
|
April 7, 2020
In vivo biodistribution of calcium phosphate nanoparticles after intravascular, intramuscular, intratumoral, and soft tissue administration in mice investigated by small animal PET/CT
Sebastian A Kollenda, Jasmin Klose, Torben Knuschke, et al.
Cancer Research
|
August 10, 2012
FLT-PET is superior to FDG-PET for very early response prediction in NPM-ALK-positive lymphoma treated with targeted therapy
Zhoulei Li, Nicolas Graf, Ken Herrmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 4, 2020
Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer
Stefano Fanti, Karolien Goffin, Boris A Hadaschik, et al.
Page
of 73
Search research articles
Search
Showing results (361-370 of 721) with videos related to
Sort By:
Page
of 73
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 18, 2008
SPECT/CT
Andreas K Buck, Stephan Nekolla, Sibylle Ziegler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 23, 2026
PSMA-PET response under [<sup>177</sup>Lu]Lu-PSMA therapy: Comparison of RECIST, PERCIST, PPP, adapted PCWG4 and RECIP criteria
Tugce Telli, Madeleine J Karpinski, Robert Seifert, et al.
Oncotarget
|
July 1, 2014
Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCL
Ken Herrmann, Andreas K Buck, Tibor Schuster, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 17, 2024
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials
Caroline Stokke, Silvano Gnesin, Johannes Tran-Gia, et al.
European Urology
|
October 20, 2024
Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers
Martina Sollini, Jeremie Calais, Arturo Chiti, et al.
Nuclear Medicine Communications
|
September 12, 2018
Impact of prompt gamma coincidence correction on absorbed dose estimation in differentiated thyroid cancer using 124I PET/CT imaging
Roel Wierts, Maurizio Conti, Anouk G G Claessen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 3, 2021
Novel CYP11B-ligand [<sup>123/131</sup>I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Britta Heinze, Andreas Schirbel, Lukas Nannen, et al.
Acta Biomaterialia
|
April 7, 2020
In vivo biodistribution of calcium phosphate nanoparticles after intravascular, intramuscular, intratumoral, and soft tissue administration in mice investigated by small animal PET/CT
Sebastian A Kollenda, Jasmin Klose, Torben Knuschke, et al.
Cancer Research
|
August 10, 2012
FLT-PET is superior to FDG-PET for very early response prediction in NPM-ALK-positive lymphoma treated with targeted therapy
Zhoulei Li, Nicolas Graf, Ken Herrmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 4, 2020
Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer
Stefano Fanti, Karolien Goffin, Boris A Hadaschik, et al.
Page
of 73